Optimizing the Dosing Regimen of Cetuximab and Ramucirumab Using the Model-Informed Drug Development Paradigm.
Ni L, Khan AZ, Long A, Gao L, Toms N, Gonzalez-Gugel E, Holsmer-Brand S, Lin Y, Abada P, Dickin S, O'Dea D, Wei R, Jen MH, Aggarwal H.
Ni L, et al. Among authors: dickin s.
Clin Pharmacol Ther. 2023 Jul;114(1):77-87. doi: 10.1002/cpt.2919. Epub 2023 May 11.
Clin Pharmacol Ther. 2023.
PMID: 37087634
Review.